FDA inspection
CSL Plasma Inc.: FDA inspection ending Aug 6, 2004
FDA inspection 339613 · Voluntary Action Indicated (VAI) · Union, SC
Key facts
| Inspection ID | 339613 |
|---|---|
| Firm | CSL Plasma Inc. |
| FEI number | 1053087 |
| Address | 155 Medical Sciences Dr |
| City | Union |
| State | SC |
| ZIP | 29379-8609 |
| Fiscal year | 2004 |
| Inspection end date | Aug 6, 2004 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation|Blood and Blood Products|Drug Quality Assurance|Generic Drug Evaluation |
| Product type | Biologics, Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data